Track artwork

Tamiflu US Press Conference

BMJ talk medicine on April 09, 2014 13:53

Play
0.00 / 32.34
Hide the comments

Stats for this track

This Week Total
Plays 9390
Favoritings 1
Downloads 1 78

Uploaded by

  • Report copyright infringement

    In 1 Set

    More tracks by BMJ talk medicine

    Diagnosing and treating acute hamstring injuries

    "Is climbing Everest good for my heart, doctor?"

    Assoc Prof Kay Crossley on procedures for patellofemoral pain

    Mortality on match days of the German national soccer team

    Managing muscle injuries – Does the Munich Consensus Statement help? Part 2 of 2

    View all

    Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported.

    Here is the audio of a recent press conference where researchers and the BMJ's editors describe the findings of that research, and the systematic regulatory failures those findings expose.

    Taking part were:
    Fiona Godlee - BMJ editor in chief
    Carl Heneghan - Director of Oxford University's Centre for Evidence Based Medicine
    Peter Doshi - Assistant Professor of Pharmaceutical Health Services Research
    Elizabeth Loder - The BMJ clinical epidemiology editor
    David Tovey - Editor in chief, Cochrane Library
    Ben Goldacre - Founder of the AllTrials campaign

    Add a new comment

    You need to be logged in to post a comment. If you're already a member, please or sign up for a free account.

    Share to WordPress.com

    If you are using self-hosted WordPress, please use our standard embed code or install the plugin to use shortcodes.
    Add a comment 0 comments at 0.00
      Click to enter a
      comment at
      0.00